一项基于MAOA和皮下肌肉脂肪特征的研究预测了术后晚期胃癌患者的长期生存能力
Yubo Han1, Yaoyuan Chang1, Jiaqi Wang1
1Department of General Surgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
World journal of surgical oncology
|July 15, 2024
概括
这项研究整合了免疫组织化学和放射学,以预测晚期胃癌 (AGC) 的长期存活率. 将MAOA表达和放射性风险评分结合起来,可以提高AGC患者的预后准确性.
科学领域:
- 在瘤学瘤学.
- 医疗成像医学成像
- 生物标志物 生物标志物
背景情况:
- 晚期胃癌 (AGC) 的预后不好,需要准确的生存预测.
- 放射学和免疫组织化学是癌症研究中的新兴工具.
- 放射学和免疫组织化学对AGC存活的联合预测价值尚未得到充分研究.
研究的目的:
- 开发和验证一个临床预测模型,用于在晚期胃癌患者的长期存活.
- 研究放射性特征和MAOA表达在预测整体存活率 (OS) 和疾病特异性存活率 (DSS) 中的联合实用性.
主要方法:
- 分析了90名经过彻底手术的晚期胃癌患者的队列.
- 免疫组织化学被用来量化MAOA表达 (MAOAHScore).
- 从CT图像中提取了放射性特征,并使用拉索-考克斯回归开发了放射性风险评分. 构建了一个包含风险得分,MAOAHScore和TNM阶段的预测模型.
主要成果:
- 该预测模型确定了放射性风险评分,MAOAHScore和TNM阶段作为3年OS和DSS的独立预测因素.
- 诺米图实现了OS的AUC值为0.81和DSS的AUC值为0.797.
- 校准和决策曲线分析证实了该模型的良好预测性能和临床实用性.
结论:
- 结合免疫组织化学 (MAOA表达) 和放射性特征,可以更准确地预测晚期胃癌的长期存活率.
- 这项研究提供了新的见解和改善AGC生存预测的实用工具.
相关概念视频
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
01:20Comparing the Survival Analysis of Two or More Groups
175
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
175